Zhejiang Sunflower Great Health Co., Ltd. (SHE:300111)
China · Delayed Price · Currency is CNY 4.580
+0.020 (0.44%)
Feb 4, 2026, 1:35 PM CST
SHE:300111 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 301.75 | 329.2 | 334.96 | 332.63 | 295.56 | 285.01 |
Other Revenue | 1.17 | 1.17 | 3.46 | 3.23 | 1.73 | 1.94 |
| 302.92 | 330.37 | 338.42 | 335.86 | 297.29 | 286.96 | |
Revenue Growth (YoY) | -8.28% | -2.38% | 0.76% | 12.97% | 3.60% | -65.70% |
Cost of Revenue | 241.91 | 256.14 | 254.82 | 239.68 | 188.39 | 184.63 |
Gross Profit | 61.01 | 74.23 | 83.6 | 96.17 | 108.9 | 102.32 |
Selling, General & Admin | 51.95 | 60.84 | 86.87 | 83.95 | 83.48 | 71.22 |
Research & Development | 12.68 | 19.09 | 19.11 | 14.19 | 12.27 | 11.34 |
Other Operating Expenses | 2.39 | 2.39 | 2.44 | 1.02 | 2.24 | -1.36 |
Operating Expenses | 67.26 | 82.35 | 70.81 | 99.02 | 59.45 | 44.28 |
Operating Income | -6.26 | -8.12 | 12.79 | -2.84 | 49.45 | 58.05 |
Interest Expense | - | -1.74 | -4.56 | -0.44 | -0.06 | -2.22 |
Interest & Investment Income | 13.68 | 17.84 | 15.11 | 7.5 | 6.41 | 4.88 |
Currency Exchange Gain (Loss) | 1.94 | 1.94 | 1.47 | 1.23 | -0.21 | -1.26 |
Other Non Operating Income (Expenses) | -0.65 | -0.16 | -0.1 | -0.58 | -0.28 | 17.44 |
EBT Excluding Unusual Items | 8.7 | 9.76 | 24.71 | 4.87 | 55.32 | 76.88 |
Gain (Loss) on Sale of Assets | 0.11 | - | - | -0 | -4.56 | 0.28 |
Asset Writedown | -1.91 | -0.19 | -0.12 | -0.07 | -0.1 | -0.11 |
Legal Settlements | - | - | - | - | -0.04 | -8.1 |
Other Unusual Items | 3.01 | 3 | 0.31 | -0.17 | 18.69 | 2 |
Pretax Income | 9.91 | 12.58 | 24.9 | 4.63 | 69.31 | 70.96 |
Income Tax Expense | -1.58 | -0.78 | 0.99 | 0.07 | 3.44 | 3.59 |
Earnings From Continuing Operations | 11.49 | 13.36 | 23.91 | 4.56 | 65.87 | 67.36 |
Minority Interest in Earnings | -5.14 | -5.53 | -2.16 | -5.69 | -12.46 | -11.49 |
Net Income | 6.35 | 7.83 | 21.75 | -1.14 | 53.42 | 55.87 |
Net Income to Common | 6.35 | 7.83 | 21.75 | -1.14 | 53.42 | 55.87 |
Net Income Growth | 956.47% | -64.01% | - | - | -4.39% | - |
Shares Outstanding (Basic) | 1,240 | 1,305 | 1,279 | 1,139 | 1,113 | 1,120 |
Shares Outstanding (Diluted) | 1,240 | 1,305 | 1,279 | 1,139 | 1,113 | 1,120 |
Shares Change (YoY) | -10.10% | 1.97% | 12.35% | 2.32% | -0.62% | -2.57% |
EPS (Basic) | 0.01 | 0.01 | 0.02 | -0.00 | 0.05 | 0.05 |
EPS (Diluted) | 0.01 | 0.01 | 0.02 | -0.00 | 0.05 | 0.05 |
EPS Growth | 1077.01% | -64.71% | - | - | -3.79% | - |
Free Cash Flow | -19.7 | 18.55 | -7.43 | -17.99 | 82.38 | 30.95 |
Free Cash Flow Per Share | -0.02 | 0.01 | -0.01 | -0.02 | 0.07 | 0.03 |
Gross Margin | 20.14% | 22.47% | 24.70% | 28.63% | 36.63% | 35.66% |
Operating Margin | -2.07% | -2.46% | 3.78% | -0.85% | 16.63% | 20.23% |
Profit Margin | 2.10% | 2.37% | 6.43% | -0.34% | 17.97% | 19.47% |
Free Cash Flow Margin | -6.50% | 5.61% | -2.19% | -5.36% | 27.71% | 10.79% |
EBITDA | 10.29 | 8.64 | 29.84 | 12.81 | 68.55 | 76.97 |
EBITDA Margin | 3.40% | 2.62% | 8.82% | 3.81% | 23.06% | 26.82% |
D&A For EBITDA | 16.54 | 16.76 | 17.05 | 15.65 | 19.1 | 18.93 |
EBIT | -6.26 | -8.12 | 12.79 | -2.84 | 49.45 | 58.05 |
EBIT Margin | -2.07% | -2.46% | 3.78% | -0.85% | 16.63% | 20.23% |
Effective Tax Rate | - | - | 3.98% | 1.54% | 4.96% | 5.07% |
Revenue as Reported | 302.92 | 330.37 | 338.42 | 335.86 | 297.29 | 286.96 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.